Masimo Corporation - Common Stock (NQ:MASI)

179.95 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

2 Under-the-Radar Medtech Stocks to Buy Now ↗

November 05, 2022

Don't count out these discounted medical technology stocks.

Via The Motley Fool

Masimo to Report Third Quarter 2022 Financial Results after Market Close on Tuesday, November 8

October 25, 2022

From Masimo

Via Business Wire

NASDAQ:MASI Investor Notice: Investigation over Possible Securities Laws Violations by Masimo Corporation ↗

October 25, 2022

San Diego, CA -- (SBWIRE) -- 10/25/2022 -- An investigation was announced concerning possible violations of securities laws by Masimo Corporation in connection with certain financial statements.

Via SBWire

Masimo Sets the Record Straight on Bylaw Amendments

October 21, 2022

From Masimo

Via Business Wire

Politan Capital Management Takes Legal Action in Response to Masimo’s Attempts to Eliminate Stockholder Rights

October 21, 2022

From Politan Capital Management

Via Business Wire

Where Masimo Stands With Analysts ↗

October 12, 2022

Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where Masimo Stands With Analysts ↗

September 14, 2022

Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings:

Via Benzinga

Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations ↗

August 10, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

7 Analysts Have This to Say About Masimo ↗

May 04, 2022

Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:

Via Benzinga

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues ↗

May 04, 2022

Via Benzinga

Accenture Price Target Cut By This Analyst, Plus Deutsche Bank Predicts $483 For FactSet Research ↗

September 23, 2022

Credit Suisse cut FedEx Corporation (NYSE: FDX) price target from $246 to $236. FedEx shares fell 1.9% to $151.56 in pre-market trading.

Via Benzinga

Masimo Appoints New Leader for Consumer Division

September 19, 2022

From Masimo

Via Business Wire

Medical Pioneer Masimo Announces the Full Market Consumer Release of the Masimo W1™, the First Watch to Offer Accurate, Continuous Health Data

August 31, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022 ↗

September 15, 2022

Upgrades

Via Benzinga

Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes ↗

August 10, 2022

RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 ↗

September 14, 2022

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...

Via Benzinga

Masimo Reports Second Quarter 2022 Financial Results

August 09, 2022

From Masimo

Via Business Wire

Masimo to Report Second Quarter 2022 Financial Results after Market Close on Tuesday, August 9

July 26, 2022

From Masimo

Via Business Wire

Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery

July 20, 2022

From Masimo

Via Business Wire

7 Best High-Growth Stocks for Young Investors ↗

July 19, 2022

The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive.

Via InvestorPlace

Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients

July 05, 2022

From Masimo

Via Business Wire

New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients

May 23, 2022

From Masimo

Via Business Wire

Masimo's Return on Invested Capital Insights ↗

May 13, 2022

According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

Masimo Reports First Quarter 2022 Financial Results

May 03, 2022

From Masimo

Via Business Wire

Masimo's Earnings Outlook ↗

May 02, 2022

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...

Via Benzinga

Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers

May 02, 2022

From Masimo

Via Business Wire

Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery

April 25, 2022

From Masimo

Via Business Wire

New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond

April 18, 2022

From Masimo

Via Business Wire

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.